Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Conditions: Diffuse Astrocytoma, IDH-Mutant; Glioblastoma, IDH-wildtype; Brain Metastases, Adult; Cervical Cancer; Colorectal Cancer; Esophageal Cancer; Esophageal Squamous Cell Carcinoma; Gastric Cancer; Gastroesophageal Junction Adenocarcinoma; Head and Neck Squ amous Cell Carcinoma; Melanoma; Merkel Cell Carcinoma; Microsatellite Instability-High Solid Malignant Tumor; Mismatch Repair Deficient Solid Malignant Tumor; Microsatellite Instability-High Colorectal Cancer; Mismatch Repair Deficient Colorectal Cancer; Non-smal l Cell Lung Ca...
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Preclinical Brain Tumor Models
Conditions: Brain Metastases; Diffuse Gliomas Intervention: Other: Fresh tumor sampling Sponsor: Assistance Publique Hopitaux De Marseille Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Conditions: Diffuse Astrocytoma, IDH-Mutant; Glioblastoma, IDH-wildtype; Brain Metastases, Adult; Cervical Cancer; Colorectal Cancer; Esophageal Cancer; Esophageal Squamous Cell Carcinoma; Gastric Cancer; Gastroesophageal Junction Adenocarcinoma; Head and Neck Squ amous Cell Carcinoma; Melanoma; Merkel Cell Carcinoma; Microsatellite Instability-High Solid Malignant Tumor; Mismatch Repair Deficient Solid Malignant Tumor; Microsatellite Instability-High Colorectal Cancer; Mismatch Repair Deficient Colorectal Cancer; Non-smal l Cell Lung Ca...
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
Conditions: Brain Metastases; Brain Metastases, Adult; Brain Cancer Intervention: Drug: 18F fluciclovine Sponsors: Baptist Health South Florida; Blue Earth Diagnostics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases
Conditions: Breast Cancer; Metastatic Breast Cancer Intervention: Drug: Trastuzumab-Deruxtecan (T-DXd) Sponsors: MedSIR; Daiichi Sankyo, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
Conditions: Brain Metastases; Brain Metastases, Adult; Brain Cancer Intervention: Drug: 18F fluciclovine Sponsors: Baptist Health South Florida; Blue Earth Diagnostics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases
Conditions: Breast Cancer; Metastatic Breast Cancer Intervention: Drug: Trastuzumab-Deruxtecan (T-DXd) Sponsors: MedSIR; Daiichi Sankyo, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Conditions: Diffuse Astrocytoma, IDH-Mutant; Glioblastoma, IDH-wildtype; Brain Metastases, Adult; Cervical Cancer; Colorectal Cancer; Esophageal Cancer; Esophageal Squamous Cell Carcinoma; Gastric Cancer; Gastroesophageal Junction Adenocarcinoma; Head and Neck Squ amous Cell Carcinoma; Melanoma; Merkel Cell Carcinoma; Microsatellite Instability-High Solid Malignant Tumor; Mismatch Repair Deficient Solid Malignant Tumor; Microsatellite Instability-High Colorectal Cancer; Mismatch Repair Deficient Colorectal Cancer; Non-smal l Cell Lung Ca...
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Preclinical Brain Tumor Models
Conditions: Brain Metastases; Diffuse Gliomas Intervention: Other: Fresh tumor sampling Sponsor: Assistance Publique Hopitaux De Marseille Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases
Conditions: Breast Cancer; Metastatic Breast Cancer Intervention: Drug: Trastuzumab-Deruxtecan (T-DXd) Sponsors: MedSIR; Daiichi Sankyo, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Conditions: Diffuse Astrocytoma, IDH-Mutant; Glioblastoma, IDH-wildtype; Brain Metastases, Adult; Cervical Cancer; Colorectal Cancer; Esophageal Cancer; Esophageal Squamous Cell Carcinoma; Gastric Cancer; Gastroesophageal Junction Adenocarcinoma; Head and Neck Squ amous Cell Carcinoma; Melanoma; Merkel Cell Carcinoma; Microsatellite Instability-High Solid Malignant Tumor; Mismatch Repair Deficient Solid Malignant Tumor; Microsatellite Instability-High Colorectal Cancer; Mismatch Repair Deficient Colorectal Cancer; Non-smal l Cell Lung Ca...
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
Conditions: Brain Metastases; Brain Metastases, Adult; Brain Cancer Intervention: Drug: 18F fluciclovine Sponsors: Baptist Health South Florida; Blue Earth Diagnostics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Preclinical Brain Tumor Models
Conditions: Brain Metastases; Diffuse Gliomas Intervention: Other: Fresh tumor sampling Sponsor: Assistance Publique Hopitaux De Marseille Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases
Conditions: Breast Cancer; Metastatic Breast Cancer Intervention: Drug: Trastuzumab-Deruxtecan (T-DXd) Sponsors: MedSIR; Daiichi Sankyo, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials